Skip to main content
Premium Trial:

Request an Annual Quote

Illumina, FlowJo to Develop, Comarket Single-Cell Genomics Software

NEW YORK (GenomeWeb) – Illumina and FlowJo today announced a partnership to jointly develop and comarket software for analyzing single-cell next-generation sequencing data.

Ashland, Oregon-based FlowJo develops analysis solutions based on technology from Stanford University for single-cell flow and mass cytometry data analysis. Under the terms of the agreement with Illumina, FlowJo will develop a new software application for secondary and tertiary analysis and visualization of datasets. The application will be integrated with a single-cell RNA application available on Illumina's BaseSpace cloud infrastructure, Illumina said. It will also complement an end-to-end commercial solution for high-throughput sequencing of single cells that Illumina is co-developing with Bio-Rad Laboratories, the company added. 

"The new offering will enhance the power of single-cell biology research by empowering robust exploration of data from Illumina next-generation sequencing runs," FlowJo CEO Michael Stadnisky said in a statement. "We are excited to partner with Illumina on this project to bring new tools for analyzing and visualizing NGS data to cell biology."

The partners expect to have the software ready for market in the first quarter of 2017.

Financial and other terms of the agreement were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.